Research in context panel:
"Our IPDMA presents the most comprehensive summary of all existing randomised evidence (including >96% of participants recruited globally on the topic) and subgroup analyses settling the issue of discordant guidelines. JAK inhibitors seem a safe and efficacious treatment option for adults hospitalised with COVID-19 when given in addition to usual care."
π° New Article: Effects of Janus kinase inhibitors in adults admitted to hospital with #COVID19: a systematic review and IPD meta-analysis of randomised clinical trials
Findings suggested that JAK inhibitors reduced mortality across all levels of respiratory support
π tinyurl.com/2hprv99v
14.05.2025 13:55
π 5
π 7
π¬ 1
π 0
Our HIV programme is collapsing β and our government is nowhere to be seen
But urgent action can save us
"Get the experts into the room, and get a plan together...We donβt need perfection, but we do need urgency. The health system that is delivering HIV care is unravelling now.
The cost of doing nothing is millions of lives and a shattered legacy." @francoisventer.bsky.social
23.04.2025 09:39
π 5
π 6
π¬ 0
π 0
Chloe Orkin: forefronting social justice in medicine
HIV researcher and physician Chloe Orkin, Professor of Infection and Inequities at
Queen Mary University of London, UK, embarked on her career at the age of just 16
years when she began her medical de...
Delighted to see Prof @profchloeorkin.bsky.social, Director @shareeastlondon.bsky.social & Consultant HIV physician at Barts Health, profiled in @thelancet.bsky.social today. Great to learn more about her career, with βequality at its heart, motivated by activismβ www.thelancet.com/journals/lan...
31.01.2025 10:25
π 18
π 7
π¬ 0
π 3
Data sharing is a big hurdle in Individual Participant Data Mata Analysis (#IPDMA).
Matthias Briel and @alainamstutz.bsky.social participated at a EOSC-ENTRUST workshop to address this problem.
More: ecrin.org/news/eosc-en...
@ecrin.bsky.social #UniversityofOslo
#HealthDataResearchUK
31.01.2025 11:12
π 4
π 1
π¬ 0
π 0
An issue that often comes up is how to set a βnon-inferiority marginβ in a non-inferiority trial and how to ensure it is appropriate 1/8
#MethodologyMonday #109
27.01.2025 07:32
π 35
π 22
π¬ 2
π 3